Not applicableStudy completedNCT01550393What this trial is testingBiomarkers in Urine Samples From Patients With Wilms TumorWho this might be right forKidney Cancer Children's Oncology Group 100
Early research (Phase 1)Study completedNCT01222780What this trial is testingTo Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerWho this might be right forSarcomaNeuroblastomaWilms Tumor+3 more Acrotech Biopharma Inc. 22
Large-scale testing (Phase 3)UnknownNCT00047138What this trial is testingChemotherapy Before and After Surgery in Treating Children With Wilm's TumorWho this might be right forKidney Cancer University of Leicester 350
Early research (Phase 1)Study completedNCT01621542What this trial is testingClinical Study of WT2725 in Patients With Advanced MalignanciesWho this might be right forCancer Sumitomo Pharma America, Inc. 64
Post-approval studies (Phase 4)Study completedNCT00336531What this trial is testingEfficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell TransplantationWho this might be right forNeuroblastomaBrain TumorRetinoblastoma+2 more Samsung Medical Center 100
Early research (Phase 1)Study completedNCT00931931What this trial is testingHSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsWho this might be right forRhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more Timothy Cripe 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT01169584What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsWho this might be right forNeuroblastomaRhabdomyosarcomaLymphoma+2 more Jennerex Biotherapeutics 6
Large-scale testing (Phase 3)UnknownNCT00003804What this trial is testingChemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' TumorWho this might be right forKidney Cancer University of Leicester 350
Large-scale testing (Phase 3)Active Not RecruitingNCT00945009What this trial is testingCombination Chemotherapy and Surgery in Treating Young Patients With Wilms TumorWho this might be right forAdult Kidney Wilms TumorBeckwith-Wiedemann SyndromeChildhood Kidney Wilms Tumor+7 more Children's Oncology Group 249
Testing effectiveness (Phase 2)Study completedNCT00405327What this trial is testingA Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell TransplantationWho this might be right forSarcomaNeuroblastomaWilm's Tumor University of Michigan Rogel Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 44
Not applicableWithdrawnNCT00624962What this trial is testingEarly Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney CancerLeukemia+4 more Vanderbilt University
Testing effectiveness (Phase 2)Ended earlyNCT03311334What this trial is testingDSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more Sumitomo Pharma America, Inc. 47
Large-scale testing (Phase 3)Study completedNCT03149003What this trial is testingDSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyWho this might be right forGlioblastoma Sumitomo Pharma America, Inc. 221
Testing effectiveness (Phase 2)Ended earlyNCT02624388What this trial is testingStudy of Genistein in Pediatric Oncology Patients (UVA-Gen001)Who this might be right forLymphomaChildhood LymphomaSolid Tumor+13 more University of Virginia 4
Testing effectiveness (Phase 2)Looking for participantsNCT05135975What this trial is testingCabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsWho this might be right forNeuroblastomaSarcoma Nationwide Children's Hospital 86
Not applicableStudy completedNCT00897637What this trial is testingGene Expression Profiles to Categorize Wilms TumorsWho this might be right forRecurrent Wilms Tumor and Other Childhood Kidney TumorsStage I Wilms TumorStage II Wilms Tumor+3 more Children's Oncology Group 600
Early research (Phase 1)Active Not RecruitingNCT04377932What this trial is testingInterleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsWho this might be right forLiver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more Baylor College of Medicine 14
Large-scale testing (Phase 3)Study completedNCT00008359What this trial is testingCaspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentWho this might be right forCancer Memorial Sloan Kettering Cancer Center